Identification of the major tamoxifenDNA adducts in rat liver by mass spectroscopy
Authors:
Open Access
- 1 February 1999
- journal article
- research article
- Published by Oxford University Press (OUP) in Carcinogenesis
- Vol. 20 (2) , 305-309
Abstract
We present here the first mass spectroscopic (MS) identification of the main tamoxifen-induced DNA adducts in rat liver. The two main adducts were isolated by high-performance liquid chromatography (HPLC) and identified by MS, MS–MS and ultraviolet spectroscopy. Adduct 1 was the N-desmethyltamoxifen–deoxyguanosine adduct in which the α-position of the metabolite N-desmethyltamoxifen is linked covalently to the amino group of deoxyguanosine. Adduct 2 was confirmed to be the trans isomer of α-(N2-deoxyguanosinyl)tamoxifen, as previously suggested by co-chromatography.Keywords
This publication has 16 references indexed in Scilit:
- DNA adduct formation by tamoxifen and structurally-related compounds in rat liverChemico-Biological Interactions, 1998
- Identification of Tamoxifen−DNA Adducts Formed by α-Sulfate Tamoxifen and α-AcetoxytamoxifenChemical Research in Toxicology, 1997
- Conformational Studies and Electronic Structures of Tamoxifen and Toremifene and Their Allylic Carbocations Proposed as Reactive Intermediates Leading to DNA Adduct FormationJournal of Medicinal Chemistry, 1996
- Identification of tamoxifen metabolites in human Hep G2 cell line, human liver homogenate, and patients on long-term therapy for breast cancer.Drug Metabolism and Disposition, 1995
- Tamoxifen: evidence by 32P–postlabeling and use of metabolic inhibitors for two distinct pathways leading to mouse hepatic DNA adduct formation and identification of 4–hydroxytamoxifen as a proximate metaboliteCarcinogenesis, 1994
- Studies of tamoxifen as a promoter of hepatocarcinogenesis in female Fischer F344 ratsBreast Cancer Research and Treatment, 1994
- Analysis of phase I and phase II metabolites of tamoxifen in breast cancer patients.Drug Metabolism and Disposition, 1993
- Metabolism of the antimammary cancer antiestrogenic agent tamoxifen. I. Cytochrome P-450-catalyzed N-demethylation and 4-hydroxylation.Drug Metabolism and Disposition, 1993
- Genotoxic potential of tamoxifen and analogues in female Fischer F344/n rats, DBA/2 and C57BL/6 mice and in human MCL-5 cellsCarcinogenesis, 1992
- Determination of tamoxifen and biologically active metabolites in human breast tumours and plasmaEuropean Journal of Cancer and Clinical Oncology, 1981